N-(5-Aminopentyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide hydrochloride

Catalog No.: 
ACXOQM422
CAS No.: 
2716130-28-6
Molecular Formula: 
C20H25ClN4O6
Molecular Weight: 
452.89
N-(5-Aminopentyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg98%$400.00InquiryInquiry
50mg98%$598.00InquiryInquiry
100mg98%$893.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(5-Aminopentyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide hydrochloride
IUPAC NameN-(5-aminopentyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide hydrochloride
Molecular FormulaC20H25ClN4O6
Molecular Weight452.89
SMILESO=C(NCCCCCN)COC1=CC=CC(C(N2C(CC3)C(NC3=O)=O)=O)=C1C2=O.[H]Cl
InChI KeyZKCWBVKAAVYCJY-UHFFFAOYSA-N
SynonymN-(5-Aminopentyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide hydrochloride;Acetamide, N-(5-aminopentyl)-2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]-, hydrochloride (1:1)
CAS No.2716130-28-6

Synthetic Route by SureRoute

1. ACXOQM422 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXOQM422 route product structure diagram
    ACXOQM4222716130-28-6
Inquiry

2. ACXOQM422 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXOQM422 route product structure diagram
    ACXOQM4222716130-28-6
Inquiry

3. ACXOQM422 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXOQM422 route product structure diagram
    ACXOQM4222716130-28-6
Inquiry

Comments (0)